Key Statistics
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Dec 4, 2025 | Scotiabank | |
| Dec 2, 2025 | Goldman Sachs | |
| Nov 24, 2025 | Wells Fargo | |
| Nov 18, 2025 | Deutsche Bank | |
| Nov 3, 2025 | Morgan Stanley |